203 related articles for article (PubMed ID: 25185936)
1. Costs associated with severe and nonsevere systemic lupus erythematosus in Canada.
Clarke AE; Urowitz MB; Monga N; Hanly JG
Arthritis Care Res (Hoboken); 2015 Mar; 67(3):431-6. PubMed ID: 25185936
[TBL] [Abstract][Full Text] [Related]
2. The impact of flare on disease costs of patients with systemic lupus erythematosus.
Zhu TY; Tam LS; Lee VW; Lee KK; Li EK
Arthritis Rheum; 2009 Sep; 61(9):1159-67. PubMed ID: 19714597
[TBL] [Abstract][Full Text] [Related]
3. The cost of care of systemic lupus erythematosus (SLE) in the UK: annual direct costs for adult SLE patients with active autoantibody-positive disease.
Khamashta MA; Bruce IN; Gordon C; Isenberg DA; Ateka-Barrutia O; Gayed M; Donatti C; Guillermin AL; Foo J; Perna A
Lupus; 2014 Mar; 23(3):273-83. PubMed ID: 24356612
[TBL] [Abstract][Full Text] [Related]
4. Annual direct medical cost of active systemic lupus erythematosus in five European countries.
Doria A; Amoura Z; Cervera R; Khamastha MA; Schneider M; Richter J; Guillemin F; Kobelt G; Maurel F; Garofano A; Perna A; Murray M; Schmitt C; Boucot I
Ann Rheum Dis; 2014 Jan; 73(1):154-60. PubMed ID: 23264339
[TBL] [Abstract][Full Text] [Related]
5. Direct medical costs and their predictors in South Korean patients with systemic lupus erythematosus.
Park SY; Joo YB; Shim J; Sung YK; Bae SC
Rheumatol Int; 2015 Nov; 35(11):1809-15. PubMed ID: 26254885
[TBL] [Abstract][Full Text] [Related]
6. Healthcare utilization and cost of systemic lupus erythematosus in a US managed care health plan.
Garris C; Jhingran P; Bass D; Engel-Nitz NM; Riedel A; Dennis G
J Med Econ; 2013; 16(5):667-77. PubMed ID: 23425294
[TBL] [Abstract][Full Text] [Related]
7. Direct cost of management and treatment of active systemic lupus erythematosus and its flares in Spain: the LUCIE Study.
Cervera R; Rúa-Figueroa I; Gil-Aguado A; Sabio JM; Pallarés L; Hernández-Pastor LJ; Iglesias M
Rev Clin Esp (Barc); 2013 Apr; 213(3):127-37. PubMed ID: 23398815
[TBL] [Abstract][Full Text] [Related]
8. Impact of early versus late systemic lupus erythematosus diagnosis on clinical and economic outcomes.
Oglesby A; Korves C; Laliberté F; Dennis G; Rao S; Suthoff ED; Wei R; Duh MS
Appl Health Econ Health Policy; 2014 Apr; 12(2):179-90. PubMed ID: 24573911
[TBL] [Abstract][Full Text] [Related]
9. Clinical profile and direct medical cost of care of adults presenting with systemic lupus erythematosus in Italy.
Doria A; Iaccarino L; La Montagna G; Mathieu A; Piga M; Galeazzi M; Iuliano A; Maurel FB; Garofano AM; Perna AG; Porcasi RE
Clin Exp Rheumatol; 2015; 33(3):375-84. PubMed ID: 26005879
[TBL] [Abstract][Full Text] [Related]
10. Disease severity and economic burden in Japanese patients with systemic lupus erythematosus: A retrospective, observational study.
Tanaka Y; Mizukami A; Kobayashi A; Ito C; Matsuki T
Int J Rheum Dis; 2018 Aug; 21(8):1609-1618. PubMed ID: 30146745
[TBL] [Abstract][Full Text] [Related]
11. [Cost of systemic lupus erythematosus for adult patients with active and treated disease in France (LUCIE study)].
Amoura Z; Deligny C; Pennaforte JL; Hamidou M; Blanco P; Hachulla E; Pourrat J; Queyrel V; Garofano A; Maurel F; Levy-Bachelot L; Boucot I
Rev Med Interne; 2014 Nov; 35(11):700-8. PubMed ID: 24630588
[TBL] [Abstract][Full Text] [Related]
12. [What factors determine the direct medical costs of patients with systemic lupus erythematosus in Germany? Subanalysis of the LUCIE study].
Richter JG; Häckel B; Manger K; Riechers E; Schmeding A; Thies W; Schneider M
Gesundheitswesen; 2014 Jan; 76(1):41-3. PubMed ID: 23512471
[TBL] [Abstract][Full Text] [Related]
13. Economic burden of systemic lupus erythematosus flares and comorbidities in a commercially insured population in the United States.
Narayanan S; Wilson K; Ogelsby A; Juneau P; Durden E
J Occup Environ Med; 2013 Nov; 55(11):1262-70. PubMed ID: 24202242
[TBL] [Abstract][Full Text] [Related]
14. Long-term medical costs and resource utilization in systemic lupus erythematosus and lupus nephritis: a five-year analysis of a large medicaid population.
Li T; Carls GS; Panopalis P; Wang S; Gibson TB; Goetzel RZ
Arthritis Rheum; 2009 Jun; 61(6):755-63. PubMed ID: 19479688
[TBL] [Abstract][Full Text] [Related]
15. The frequency of and associations with hospitalization secondary to lupus flares from the 1000 Faces of Lupus Canadian cohort.
Lee J; Peschken CA; Muangchan C; Silverman E; Pineau C; Smith CD; Arbillaga H; Zummer M; Clarke A; Bernatsky S; Hudson M; Hitchon C; Fortin PR; Pope JE
Lupus; 2013 Nov; 22(13):1341-8. PubMed ID: 24048215
[TBL] [Abstract][Full Text] [Related]
16. Economic outcomes in patients diagnosed with systemic lupus erythematosus with versus without nephritis: results from an analysis of data from a US claims database.
Pelletier EM; Ogale S; Yu E; Brunetta P; Garg J
Clin Ther; 2009 Nov; 31(11):2653-64. PubMed ID: 20110008
[TBL] [Abstract][Full Text] [Related]
17. A surge in anti-dsDNA titer predicts a severe lupus flare within six months.
Pan N; Amigues I; Lyman S; Duculan R; Aziz F; Crow MK; Kirou KA
Lupus; 2014 Mar; 23(3):293-8. PubMed ID: 24316605
[TBL] [Abstract][Full Text] [Related]
18. Systemic lupus erythematosus with neuropsychiatric manifestation incurs high disease costs: a cost-of-illness study in Hong Kong.
Zhu TY; Tam LS; Lee VW; Lee KK; Li EK
Rheumatology (Oxford); 2009 May; 48(5):564-8. PubMed ID: 19269959
[TBL] [Abstract][Full Text] [Related]
19. Frequency, severity and costs of flares increase with disease severity in newly diagnosed systemic lupus erythematosus: a real-world cohort study, United States, 2004-2015.
Hammond ER; Desta B; Near AM; Wang X; Jiang M
Lupus Sci Med; 2021 Sep; 8(1):. PubMed ID: 34556546
[TBL] [Abstract][Full Text] [Related]
20. Incremental direct medical costs of systemic lupus erythematosus patients in the years preceding diagnosis: A general population-based study.
McCormick N; Marra CA; Sadatsafavi M; Aviña-Zubieta JA
Lupus; 2018 Jul; 27(8):1247-1258. PubMed ID: 29665755
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]